Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine

NCT01401491 is registered in ClinicalTrials.gov with Taipei Medical University Hospital as lead sponsor.

NCT NCT01401491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01401491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine
Lead sponsor
Taipei Medical University Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2008
Completion date
December 31, 2010
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia